|
|
The Pathophysiological Rationale for Personalized Metabolic Therapy of ASD. Promising Treatments 810
Polyakova S.I.
PhD in Medicine, Professor of the Department of Hospital Pediatrics named after academician V.A. Tabolin, Pirogov Russian National Research Medical University (RNRMU), Moscow, Russia
e-mail: polyakova1963@list.ru
A metabolic disorder is a serious problem. Changes that occur at the cellular level and are associated with biochemical processes lead to malfunctioning of the cell, and further, respectively, of tissue, organ, of the whole organism. Metabolic care is the basis of metabolic therapy. For almost every metabolic regimen of autism spectrum disorder, there is a counter-argument. For this reason, a unified approach to therapy is impossible, since, apart from the “autistic triad”, each person has his own peculiarities. At the present stage, in addition to a gluten-free and casein-free diet, vitamins of groups B and D, polyunsaturated fatty acids, various methods of microbiome correction are used in therapy, but there is no serious evidence base for the effectiveness of therapy for autism spectrum disorders. The article proposes options for the study of metabolic changes in the body, which are the rationale for the development of a scheme of metabolic therapy in the framework of a personalized medical approach to the treatment of autism spectrum disorders.
-
Volchanskaya A.A., Konareva V.R., Alenikova
Yu.B. Khimicheskii sostav razlichnykh gibridov kukuruzy [Chemical
composition of different corn hybrids]. Molodoi uchenyi [Young scientist],
2016, no. 13, pp. 914—916. URL: https://moluch.ru/archive/117/32343/ [accessed
27.03.2019]. Волчанская
А.А., Конарева В.Р., Аленикова Ю.Б. Химический состав различных гибридов кукурузы // Молодой ученый,
2016. № 13. С. 914—16. URL
https://moluch.ru/archive/117/32343
-
Bandini L.G., Anderson S.E., Curtin C., Cermak S.,
Evans E.W. et al. Food
Selectivity in Children with Autism Spectrum Disorders and Typically Developing
Children. The journal
of pediatrics, 2010,
no. 157(2), pp. 259—264. doi: 10.1016/j.jpeds.2010.02.013
-
Bernardi S., Anagnostou E., Shen J., Kolevzon A.,
Buxbaum J.D., Hollander E., et al. In vivo 1H-magnetic resonance spectroscopy study of the
attentional networks in autism. Brain Res,
2011;1380:198—205.
-
Bonnot O., Klünemann H.,
Sedel F., Torjman S. et al. Diagnostic and treatment implications of psychosis secondary to
treatable metabolic disorders in adults: a systemic review. Orphaner journal of
rare diseases, 2014, Vol. 9, pp. 65—79.
-
Campistol J., Díez-Juan M.,
Callejón L.,
Fernandez-De Miguel A., et al. Inborn error metabolic screening in individuals with nonsyndromic
autism spectrum disorders. Dev Med Child Neurol. 2016; 58(8). pp. 842—847. doi:
10.1111/dmcn.13114.
-
Courchesne E. Abnormal early brain development in autism.
Molecular psychiatry, 2002, vol. 7, pp. 21—23.
doi:10.1038/sj.mp.4001169.
-
Demily C., Sedel F. Psychiatric manifestations of treatable
hereditary metabolic disorders in adults. Annals of general psychiatry, 2014.
Vol. 13, № 1. pp. 27—6
-
DeVito T.J., Drost D.J., Neufeld R.W., Rajakumar N.,
Pavlosky W., Williamson P., et al. Evidence for cortical dysfunction in autism: a proton magnetic
resonance spectroscopic imaging study. Biol Psychiatry, 2007;61: p.
465—473.
-
Durieux A.M.S., Horder J., Mendez M.A., Egerton A.,
Williams S.C.R., Wilson C.E., Spain D., Murphy C., Robertson D., Barker G.J.,
Murphy D.G., McAlonan G.M. Cortical and subcortical glutathione levels in adults with autism
spectrum disorder. Autism Res. 2016, Apr: 9(4):429—435. doi: 10.1002/aur.1522.
Epub 2015 Aug 20.
-
Felipo V., Butterworth
RF.
Neurobiology of ammonia. Progr. Neurobiol, 2002. Vol. 67. No 4. pp.
259—279.
-
Frye R.E., Casanova M.F., Fatemi S.H., Folsom T.D.,
et al.
Neuropathological Mechanisms of Seizures in Autism Spectrum
Disorder. Frontiers in
Neuroscience, 2016,
vol. 10, pp 1—9. doi:10.3389/fnins.2016.00192
-
Fukudome S., Yoshikawa
M.
Opioid peptides derived from wheat gluten: their isolation and
characterization. FEBS
Letters, 1993,
vol. 316, pp. 17—19.
-
Hyman S., Stewart P.A., Foley J., Cain U., et
al. The
Gluten-Free/Casein-Free Diet: A Double-Blind Challenge Trial in Children with
Autism. Journal of Autism and Developmental Disorders, 2016, Vol. 46, Issue 1,
pp. 205—220.
-
Krajmalnik-Brown R., Lozupone C., Kang D-W., Adams
JB. Gut
bacteria in children with autism spectrum disorders: challenges and promise of
studying how a complex community influences a complex disease.
Microbial Ecology in Health &
Disease, 2015,
vol. 26. doi:10.3402/mehd.v26.26914
-
Lange K.W., Hauser J., Reissmann
A.
Gluten-free and casein-free diets in the therapy of autism. Curr Opin Clin Nutr
Metab Care, 2015. Nov; 18(6):572—5.
-
Lee E.J., Choi S.Y., Kim
E. NMDA
receptor dysfunction in autism spectrum disorders. Current Opinion in
Pharmacology, 2015, vol. 20, pp. 8—13. doi:
10.1016/j.coph.2014.10.00
-
Madore C., Leyrolle Q., Lacabanne C., Benmamar-Badel
A., Joffre C., Nadjar A., Layé S. Neuroinflammation in Autism: Plausible Role of Maternal
Inflammation, Dietary Omega 3, and Microbiota. Neural Plast? 2016;
3597209
-
Oriach C.S., Ruairi C. Robertson, Stanton C., John F.
Cryan., Timothy G. Dinan Food for thought: The role of nutrition in the
microbiota-gutebrain axis Clinical Nutrition Experimental, 2016. No. 6. pp.
25—38.
-
Page L.A., Daly E., Schmitz N., Simmons A., Toal F.,
Deeley Q., et al. In
vivo 1H-magnetic resonance spectroscopy study of amygdala-hippocampal and
parietal regions in autism. The American
Journal of Psychiatry, 2006, vol. 163, pp.
2189—2192.
-
-
Pusponegoro H.D., Ismael S., Firmansyah A.,
Sastroasmoro S., Vandenplas Y. Gluten and casein supplementation does not increase symptoms in
children with autism spectrum disorder. Acta Paediatr, 2015. Nov.
104(11):e500—5. doi: 10.1111/apa.13108.
-
Redcay E., Courchesne E.
When is the brain enlarged in autism?
A meta-analysis of all brain size reports. Biol Psychiatry, 2005. Jul. 1.
58(1):1—9. DOI:
10.1016/j.biopsych.2005.03.026
-
Rose C. Effect of ammonia on astrocytic glutamate uptake|release
mechanisms. J neurochem, 2006. Vol. 97 (suppl. 1). pp.
11—15.
-
Schiff M., Benoist J-F et
al.
Should Metabolic Diseases Be Systematically Screened in Nonsyndromic Autism
Spectrum Disorders? Autism and Metabolic Diseases, 2011. Vol. 6, No 7. pp.
219—32.
|
|
